Challenges of cardiovascular risk assessment in the routine rheumatology outpatient setting: An observational study of 110 rheumatoid arthritis patients

Arthritis Care and Research

Volumn 65, Issue 5, 2013, Pages 712-717

  Gossec, L ^a   Salejan, F ^b   Nataf, H ^b   Nguyen, M ^b   Gaud Listrat, V ^c   Hudry, C ^b   Breuillard, P ^b   Dernis, E ^d   Boumier, P ^e   Durandin Truffinet, M ^b   Fannius, J ^b   Fechtenbaum, J ^b   Izou Fouillot, M A ^b   Labatide Alanore, S ^b   Lebrun, A ^b   Ledevic, P ^b   Legoux, P ^b   Sacchi, A ^f   Salliot, C ^a   Sparsa, L ^a   D'André, F Lecoq ^b   Dougados, M ^a   more..

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b France ^*

^c Saint Michel sur Orge   (France)

^d CENTRE HOSPITALIER DU MANS   (France)

^e AMIENS UNIVERSITY HOSPITAL   (France)

^f F Quesnay Hospital   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; LIPID;

ADULT; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CROSS-SECTIONAL STUDY; DISEASE DURATION; DYSLIPIDEMIA; FEASIBILITY STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTPATIENT DEPARTMENT; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; RISK ASSESSMENT; RISK FACTOR;

AGED; AMBULATORY CARE; ARTHRITIS, RHEUMATOID; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; RHEUMATOLOGY; RISK ASSESSMENT;

EID: 84876738738     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.21935     Document Type: Article

References (25)

1. Gabriel SE, Crowson CS,. Risk factors for cardiovascular disease in rheumatoid arthritis. Curr Opin Rheumatol 2012; 24: 171-6.
2. Aubry MC, Maradit-Kremers H, Reinalda MS, Crowson CS, Edwards WD, Gabriel SE,. Differences in atherosclerotic coronary heart disease between subjects with and without rheumatoid arthritis. J Rheumatol 2007; 34: 937-42.
3. Innala L, Moller B, Ljung L, Magnusson S, Smedby T, Sodergren A, et al. Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five-year prospective study. Arthritis Res Ther 2011; 13: R131.
4. Davis JM III, Maradit Kremers H, Crowson CS, Nicola PJ, Ballman KV, Therneau TM, et al. Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 2007; 56: 820-30.
5. Boyer JF, Bongard V, Cantagrel A, Jamard B, Gottenberg JE, Mariette X, et al. Link between traditional cardiovascular risk factors and inflammation in early arthritis patients: results from a French multicenter cohort. Arthritis Care Res (Hoboken) 2012; 64: 872-80.
6. Toms TE, Symmons DP, Kitas GD,. Dyslipidaemia in rheumatoid arthritis: the role of inflammation, drugs, lifestyle and genetic factors. Curr Vasc Pharmacol 2010; 8: 301-26.
7. Peters MJ, Symmons DP, McCarey D, Dijkmans BA, Nicola P, Kvien TK, et al. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 2010; 69: 325-31.
8. French Society of Rheumatology. 2012. URL: http://www.rhumatismes.net/ fichiers/Brochure-SFR-V7.pdf.
9. Soubrier M, Zerkak D, Dougados M,. Indications for lowering LDL cholesterol in rheumatoid arthritis: an unrecognized problem. J Rheumatol 2006; 33: 1766-9.
10. Toms TE, Panoulas VF, Douglas KM, Griffiths H, Sattar N, Smith JP, et al. Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatment of lipid-associated cardiovascular risk? Ann Rheum Dis 2010; 69: 683-8.
11. Keeling SO, Teo M, Fung D,. Lack of cardiovascular risk assessment in inflammatory arthritis and systemic lupus erythematosus patients at a tertiary care center. Clin Rheumatol 2011; 30: 1311-7.
12. Fechtenbaum J, Gossec L, Nataf H, Boumier P, Breuillard P, Gaud Listrat V, et al, and the Medical Network RHEVER. Professional practice assessment in ambulatory private rheumatology: a pilot evaluation of the medical file content for rheumatoid arthritis. Clin Exp Rheumatol 2008; 26: 343-6.
13. D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008; 117: 743-53.
14. Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL,. Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995; 38: 44-8.
15. Agence Francaise de Securité Sanitaire des Produits de Sante. AFSSAPS guideline for the treatment of dyslipidemia. Rev Prat 2005; 55: 1788-93. In French.
16. Gabriel SE, Crowson CS, Kremers HM, Doran MF, Turesson C, O'Fallon WM, et al. Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years. Arthritis Rheum 2003; 48: 54-8.
17. Goodson NJ, Symmons DP, Scott DG, Bunn D, Lunt M, Silman AJ,. Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year followup study of a primary care-based inception cohort. Arthritis Rheum 2005; 52: 2293-9.
18. Turesson C, McClelland RL, Christianson TJ, Matteson EL,. Severe extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritis. Ann Rheum Dis 2007; 66: 70-5.
19. American Diabetes Association. Position statements: screening for type 2 diabetes. Diabetes Care 2004; 27: s11-4.
20. National Institute for Health and Clinical Excellence (NICE). Clinical guideline 67. Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease. London: National Institute for Health and Clinical Excellence; 2010.
21. Schofield P, Chen R, Crichton N,. Methods for assessing cardiovascular disease risk in a UK black population. Heart 2012; 98: 1373-7.
22. Grover SA, Lowensteyn I,. The challenges and benefits of cardiovascular risk assessment in clinical practice. Can J Cardiol 2011; 27: 481-7.
23. Missault L, Witters N, Imschoot J,. High cardiovascular risk and poor adherence to guidelines in 11,069 patients of middle age and older in primary care centres. Eur J Cardiovasc Prev Rehabil 2010; 17: 593-8.
24. Crowson CS, Gabriel SE,. Towards improving cardiovascular risk management in patients with rheumatoid arthritis: the need for accurate risk assessment. Ann Rheum Dis 2011; 70: 719-21.
25. Bell C, Rowe IF,. The recognition and assessment of cardiovascular risk in people with rheumatoid arthritis in primary care: a questionnaire-based study of general practitioners. Musculoskeletal Care 2011; 9: 69-74.